Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Share-based Compensation (2020 - 2026)

Journey Medical filings provide 6 years of Share-based Compensation readings, the most recent being $1.8 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 28.81% to $1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.3 million, a 3.12% increase, with the full-year FY2025 number at $6.3 million, up 3.12% from a year prior.
  • Share-based Compensation hit $1.8 million in Q4 2025 for Journey Medical, down from $1.9 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $2.4 million in Q4 2021 to a low of $8000.0 in Q3 2021.
  • Median Share-based Compensation over the past 5 years was $1.3 million (2025), compared with a mean of $1.1 million.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 17875.0% in 2022 and later crashed 63.26% in 2023.
  • Journey Medical's Share-based Compensation stood at $2.4 million in 2021, then plummeted by 40.62% to $1.4 million in 2022, then crashed by 63.26% to $529000.0 in 2023, then skyrocketed by 160.49% to $1.4 million in 2024, then increased by 28.81% to $1.8 million in 2025.
  • The last three reported values for Share-based Compensation were $1.8 million (Q4 2025), $1.9 million (Q3 2025), and $1.3 million (Q2 2025) per Business Quant data.